Bert Power's Avatar

Bert Power

@bertp68

Nephrologist, Bristol UK. Enjoying clinical practice, dialysis research & national policy improvement in kidney care. Focus on stroke & CV disease. All views represent personal opinion only

610
Followers
499
Following
4
Posts
12.11.2024
Joined
Posts Following

Latest posts by Bert Power @bertp68

A bright yellow image with bold black text stating, "I'm supporting World Kidney Day." Behind the copy is the shadow of a kidney. A hashtag at the bottom reads "#KidneysMatter."

A bright yellow image with bold black text stating, "I'm supporting World Kidney Day." Behind the copy is the shadow of a kidney. A hashtag at the bottom reads "#KidneysMatter."

World Kidney Day 2026 is here! Share this post to spread the word to your followers. What are you doing to support #WorldKidneyDay this year? Share why it's important to you πŸ’›

#KidneysMatter

12.03.2026 09:08 πŸ‘ 4 πŸ” 4 πŸ’¬ 0 πŸ“Œ 0

This disease is on the rise – and many people don’t know that they have it - National Geographic

06.09.2025 22:54 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

It’s a way of getting my SBP >200 mmHg

25.02.2025 17:44 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Europe allows Novo to include reduction of kidney disease in Ozempic label The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the label of its diabetes drug Ozempic, the Danish drugmaker said in a statement on Thursday.

Europe allows Novo to include reduction of kidney disease in Ozempic label πŸ‘©β€πŸ”¬πŸ§ͺπŸ₯Ό #kidneydisease #NephSky #diabetes #weightloss #GLP-1 #Semaglutide #Ozempic #CardioSky #cardiorenal πŸ‘‡πŸ‘‡πŸ‘‡

www.reuters.com/business/hea...

12.12.2024 17:54 πŸ‘ 15 πŸ” 4 πŸ’¬ 1 πŸ“Œ 0

What options have you got in the US ? The GSK move appears commercial. In UK, Roxy for non-dialysis with vadadustat pitching for dialysis.

26.11.2024 19:43 πŸ‘ 1 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

The never-ending bane of HF / CKD meds management. Admission leads to omission.

16.11.2024 13:21 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0